CER San Juan Centro Polivalente de Asistencia e Investigación Clínica

San Juan 5400

0 studies enrolling now · 2 studies all time

What they study most

Locally Advanced or Unresectable Metastatic Breast Cancer, Metastatic Non Small Cell Lung Cancer, Stage IV Breast Cancer

Studies at this site

• Study of Dato-DXd Plus Pembrolizumab vs Pembrolizumab Alone in the First-line Treatment of Subjects With Advanced or Metastatic NSCLC Without Actionable Genomic Alterations — Running, not enrolling
• Study of Sacituzumab Govitecan Versus Treatment of Physician's Choice in Patients With Hormone Receptor-positive/Human Epidermal Growth Factor Receptor 2 Negative (HR+/HER2-) Metastatic Breast Cancer Who Have Received Endocrine Therapy — Running, not enrolling